Ustekinumab biosimilar - Bio-Thera Solutions
Alternative Names: BAT-2206; STARJEMZA; ustekinumab-hmnyLatest Information Update: 05 Jun 2025
At a glance
- Originator Bio-Thera Solutions
- Class Anti-inflammatories; Antipsoriatics; Antirheumatics; Antiulcers; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Interleukin 12 inhibitors; Interleukin 23 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Autoimmune disorders
Highest Development Phases
- Registered Crohn's disease; Plaque psoriasis; Psoriatic arthritis; Ulcerative colitis
- No development reported Autoimmune disorders